DW Insights & Inquiries
All dermatologists are subject to cognitive biases that could result in diagnostic and therapeutic errors. Embrace metacognition (self-analysis) as a pathway to determine how to be a more effective clinician.
The IL-6 inhibitor tocilizumab may have a therapeutic role in cases of recalcitrant morphea.
Anifrolumab, a monoclonal antibody that blocks type 1 interferon signaling, has been increasingly reported as an effective treatment in patients with recalcitrant chronic cutaneous lupus erythematosus.
Merkel cell carcinoma may be associated with several paraneoplastic phenomena, including the syndrome of inappropriate anti-diuretic hormone secretion, ectopic Cushing syndrome, and others.
Much remains to be learned about this enigmatic lesion and its relationship to other CD34-positive lesions such as the plaque-like CD34-positive dermal fibroma and the fibroblastic connective tissue nevus.
To improve the practice of dermatology, while being stimulating, practical, thought-provoking, and enlightening by offering critical perspectives on current dermatologic literature meant to be used in the clinic today and in the future.
Explore Dermatology World Insights and Inquiries clinical topics by practice focus, condition, and medical journal source.
All content solely developed by the American Academy of Dermatology
The American Academy of Dermatology gratefully acknowledges support from Bristol Myers Squibb.